Simplex Trading, LLC Aridis Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.16 - $0.4 $206 - $517	1,293 New	1,293 $0
Q4 2022 Feb 02, 2023	SELL	$0.81 - $1.18 $8,223 - $11,980	-10,153 Reduced 85.52%	1,719 $2,000
Q3 2022 Nov 04, 2022	SELL	$0.73 - $2.47 $1,277 - $4,322	-1,750 Reduced 12.85%	11,872 $11,000
Q2 2022 Aug 03, 2022	BUY	$0.91 - $1.7 $6,350 - $11,864	6,979 Added 105.06%	13,622 $14,000
Q1 2022 May 02, 2022	BUY	$1.33 - $2.59 $8,835 - $17,205	6,643 New	6,643 $11,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.